Zdrowie i gospodarka · 18/04/2013

FDA Requests Public Comment on Proposed Collection of Information for Drug Labeling Guidance

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to a guidance on drug labeling for cardiovascular outcome claims, as required by the Paperwork Reduction Act of 1995.